Curve Therapeutics strengthens leadership team

Privately-held UK biotech Curve Therapeutics today announced the appointment of Simon Jones to the posts of chief financial (CFO) and chief operating officer (COO) of the company, which is pioneering a revolutionary intracellular screening platform addressing complex and challenging disease targets,

Mr Jones has over 20 years of experience in the biotech and pharma sector. He is an accomplished C-Suite executive with a skill set that includes senior operational and commercial roles within the life-science sector, including significant venture fundraising and deal-making.

He joins from SpyBiotech, where he headed the finance and operations functions, during which time the company successfully took its lead vaccine candidate into the clinic. This followed almost a decade as CFO at Karus Therapeutics where he managed the financial operations as the company secured a sizeable funding round from US and EU investors, as well as investment through the UK Government’s Future Fund Scheme. Prior to this, Simon was CFO at various early-stage life sciences companies, including Eykona Technologies and Glide Pharmaceutical Technologies, which transitioned from development to commercialisation.